IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $990K of Immunovant, Inc.
Sold$990,269
$29.06Price
34,079Shares
−3%Stake
What IMVT did after the filing
- The stock from Fri, Apr 19 close, $28.22
- −10.7%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Jun 3 close.
Traded Wed, Apr 17. Filed Fri, Apr 19, 1:57 PM ET, during the session. Returns use the Apr 19 close and the Jun 3 close. Not investment advice.